A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool.

Jennifer Maloney is deputy corporate bureau chief and retail editor for The Wall Street Journal in New York. She helps oversee a team of reporters covering consumer brands, retail, manufacturing, ...

The US Food and Drug Administration (FDA ... to focus on promoting cybersecurity readiness. FDA commissioner, Scott Gottlieb, issued a statement in collaboration with the non-profit MITRE ...

A new government-issued report reflects some of the most controversial views on vaccines, the nation’s food supply, ...

Last week, the U.S. Food and Drug Administration announced a move to improve transparency and strengthen the safety of ...

US FDA aims to remove fluoride supplements for children from market The U.S. Food and Drug Administration said on Tuesday it is starting a process to remove fluoride supplements for children from ...

The U.S. Food and Drug Administration announced Friday the launch of an updated systematic review process for chemicals ...

In a conversation with The Regulatory Review, public health expert Mitch Zeller reflects on his tenure at the U.S. Food and ...

Kessler (Text Publishing) When the former head of the United States Food and Drug Administration (FDA), Dr David A. Kessler, suggests answers to these questions, it is worth pausing to listen.

Dr. Denise Eblen, who holds a doctorate in food safety microbiology from the University of Ulster at Jordanstown, is the top executive at the USDA’s Food ...

The agency is planning a new review process that could result in ingredient bans or additional labeling requirements, ...